BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cavallari I, Ciccarese F, Sharova E, Urso L, Raimondi V, Silic-Benussi M, D'Agostino DM, Ciminale V. The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers. Cancers (Basel) 2021;13:5874. [PMID: 34884985 DOI: 10.3390/cancers13235874] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Ilieva M, Panella R, Uchida S. MicroRNAs in Cancer and Cardiovascular Disease. Cells 2022;11:3551. [DOI: 10.3390/cells11223551] [Reference Citation Analysis]
2 Hashemi M, Arani HZ, Orouei S, Rostamnejad E, Ghorbani A, Khaledabadi M, Kakavand A, Tavakolpournegari A, Saebfar H, Heidari H, Salimimoghadam S, Taheriazam A, Entezari M, Khan H. Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions. Pharmacological Research 2022;185:106475. [DOI: 10.1016/j.phrs.2022.106475] [Reference Citation Analysis]
3 Ghasemi F, Alemzadeh E, Allahqoli L, Alemzadeh E, Mazidimoradi A, Salehiniya H, Alkatout I. MicroRNAs Dysregulation as Potential Biomarkers for Early Diagnosis of Endometriosis. Biomedicines 2022;10:2558. [PMID: 36289820 DOI: 10.3390/biomedicines10102558] [Reference Citation Analysis]
4 Arshinchi Bonab R, Asfa S, Kontou P, Karakülah G, Pavlopoulou A. Identification of neoplasm-specific signatures of miRNA interactions by employing a systems biology approach. PeerJ 2022;10:e14149. [DOI: 10.7717/peerj.14149] [Reference Citation Analysis]
5 Fischer C, Turchinovich A, Feisst M, Riedel F, Haßdenteufel K, Scharli P, Hartkopf AD, Brucker SY, Michel L, Burwinkel B, Schneeweiss A, Wallwiener M, Deutsch TM. Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic Treatment. IJMS 2022;23:9535. [DOI: 10.3390/ijms23179535] [Reference Citation Analysis]
6 Liao Y, Wu X, Wu M, Fang Y, Li J, Tang W. Non-coding RNAs in lung cancer: emerging regulators of angiogenesis. J Transl Med 2022;20:349. [PMID: 35918758 DOI: 10.1186/s12967-022-03553-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li T, Chen Q, Dai J, Huang Z, Luo Y, Mou T, Pu J, Yang H, Wei X, Wu Z. MicroRNA-141-3p attenuates oxidative stress-induced hepatic ischemia reperfusion injury via Keap1/Nrf2 pathway. Mol Biol Rep. [DOI: 10.1007/s11033-022-07570-3] [Reference Citation Analysis]
8 Jo H, Shim K, Jeoung D. Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics. Int J Mol Sci 2022;23:5881. [PMID: 35682560 DOI: 10.3390/ijms23115881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Pavlič A, Hauptman N, Boštjančič E, Zidar N. Long Non-Coding RNAs as Potential Regulators of EMT-Related Transcription Factors in Colorectal Cancer—A Systematic Review and Bioinformatics Analysis. Cancers 2022;14:2280. [DOI: 10.3390/cancers14092280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Shi L, Sun H, Zeng J, Liang Z, Lin Y, Huang S, Zeng J, Yang L, Chen H, Luo J, Wei K. Evaluation of miR-141-3p over-expression in ovarian cancer. Electronic Journal of Biotechnology 2022. [DOI: 10.1016/j.ejbt.2022.04.006] [Reference Citation Analysis]
11 Lee S, Kim H, Park Y, Park HG. A novel method for miRNA detection based on target-triggered transcription of a light-up RNA aptamer. Chem Commun (Camb) 2022;58:4243-6. [PMID: 35289344 DOI: 10.1039/d1cc07095a] [Reference Citation Analysis]
12 Smolarz B, Durczyński A, Romanowicz H, Szyłło K, Hogendorf P. miRNAs in Cancer (Review of Literature). Int J Mol Sci 2022;23:2805. [PMID: 35269947 DOI: 10.3390/ijms23052805] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
13 Cinque A, Capasso A, Vago R, Floris M, Lee MW, Minnei R, Trevisani F. MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer? Int J Mol Sci 2022;23:2602. [PMID: 35269744 DOI: 10.3390/ijms23052602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 纪 涵. miR-429 Inhibits Proliferation of Breast Cancer Cells by Regulating Target Gene LRP1. ACM 2022;12:2671-2682. [DOI: 10.12677/acm.2022.124384] [Reference Citation Analysis]